InvestorsHub Logo
icon url

AugustaFriends

01/10/18 8:40 AM

#398877 RE: Warchest #398874

$CHEK news The C-Scan system offers an alternative to current colon cancer screening methods that require laxative preparation and invasive endoscopic procedures. This novel platform consists of a fully autonomous system that utilizes an ingestible, ultra-low dose X-ray capsule combined with a state of the art wireless tracking system, enabling generation of structural information on the lumen of the colon. This information is used to create 2D and 3D maps of the colon, allowing physicians to identify pre-cancerous polyps and other abnormalities. C-Scan is designed to improve the patient experience and increase the number of adults screened by eliminating procedural requirements frequently cited as barriers to adherence to screening guidelines such as bowel preparation, fasting, and sedation.
Bill Densel, CEO of Check-Cap commented, "Achieving CE Mark approval is a significant accomplishment and an important milestone for our Company.  This is a key validation of C-Scan and its potential as a convenient and comfortable option for identifying polyps in the colon. We look forward to continued progress on our initiatives and remain on target to commence our European post-approval and U.S. pilot trials, each in the 1H2018, as we define marketing and commercialization pathways throughout 2018."
icon url

AugustaFriends

01/10/18 8:41 AM

#398878 RE: Warchest #398874

$CHEK Colorectal cancer is the third most common cancer diagnosed in both men and women and the second leading cause of cancer-related deaths. Despite evidence showing the removal of adenomatous polyps reduces CRC incidence and mortality, global screening rates remain low, with approximately 1.4 million new cases of CRC diagnosed world-wide each year, contributing to nearly 700,000 deaths.
icon url

AugustaFriends

01/10/18 8:41 AM

#398879 RE: Warchest #398874

$CHEK Colorectal cancer is the third most common cancer diagnosed in both men and women and the second leading cause of cancer-related deaths. Despite evidence showing the removal of adenomatous polyps reduces CRC incidence and mortality, global screening rates remain low, with approximately 1.4 million new cases of CRC diagnosed world-wide each year, contributing to nearly 700,000 deaths.
icon url

AugustaFriends

01/10/18 8:41 AM

#398880 RE: Warchest #398874

$CHEK About Check-Cap
Check-Cap is a clinical-stage medical diagnostics company developing C-Scan®, the first capsule-based system for preparation-free colorectal cancer screening.
Utilizing innovative ultra-low dose X-ray and wireless communication technologies, the capsule generates information on the contours of the inside of the colon as it passes naturally. This information is used to create a 3D map of the colon, which allows physicians to look for polyps and other abnormalities. Designed to improve the patient experience and increase the willingness of individuals to participate in recommended colorectal cancer screening, C-Scan removes many frequently-cited barriers, such as laxative bowel preparation, invasiveness and sedation.
icon url

AugustaFriends

01/10/18 8:52 AM

#398881 RE: Warchest #398874

CHEK .89 cents charts ** BIG NEWS **

ISFIYA, Israel and BOSTON, Jan.10, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (CHEK) (NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced it has received CE Mark approval for the C-Scan system.

https://finance.yahoo.com/news/check-cap-receives-ce-mark-130000402.html



Note 1: Please alert the board of any stock crossing the 20,50,20dma’s on daily or weekly chart.

(link back for more charts)

Note 2: Please do an 8x34 chart on the stock; the 8x34 cross is the initial reversal sign of most stocks. Use the link below, just replace the ticker symbol. Post on the board when a stock crosses the 8DMA or the 34DMA and when the 8x34 cross is about to occur.

check to see if your stock has 8x34 cross in the making, look at Full Sto, and CMF indicators. just replace the ticker with your TICKER

http://stockcharts.com/h-sc/ui?s=CHEK&p=D&yr=0&mn=3&dy=0&id=p11960084343







icon url

AugustaFriends

01/10/18 9:23 AM

#398883 RE: Warchest #398874

$CHEK 1.06 Break will be great with no GAP..
icon url

AugustaFriends

01/10/18 9:42 AM

#398888 RE: Warchest #398874

$CHEK .935 BUY BUY here Gap closed !!